Heart failure & cardiomyopathies
Right Ventricular Dysfunction for Prediction of Long-Term Recovery in de novo Heart Failure with Reduced Ejection Fraction (HFrEF) : A PROLONG-II Substudy
Authors' conclusion
Persistent RV dysfunction, as indicated by both standard and advanced echocardiographic markers during the early follow-up period, implies a reduced potential for long-term LV recovery in patients with newly diagnosed HFrEF.
Study context
- Population
- Patients with new-onset (de novo) HFrEF receiving a wearable cardioverter-defibrillator, from the PROLONG-II studypatients included (mean age 57 years, 68% men)
- Participants
- 260 patients
- Comparison
- Patients with long-term LV ejection fraction (LVEF) improvement vs non-improvers: Right ventricular (RV) function and right ventricular-pulmonary artery (RV-PA) coupling at baseline and 3-month follow-up (early follow-up)
- Left ventricular (LV) improvementn = 151
Primary result
As reported in the abstract
Patients with LV improvement
151
58%
Further findings
RVFWS at early follow-up as predictor of later LV recovery
| Odds ratio (95% CI) | P value | ||
|---|---|---|---|
| RVFWS at early follow-upMultivariable analysis; independent predictor | 1.078 (1.010–1.150) | P < 0.05 | |
| 0.512Odds ratio (log scale) |
All-cause mortality with RVFWS/PASP identified RV-PA uncoupling
| Hazard ratio (95% CI) | P value | ||
|---|---|---|---|
| RVFWS/PASP identified RV-PA uncouplingHigher risk with uncoupling | 4.64 (1.34–16.09) | P = 0.033 | |
| 0.050.21520Hazard ratio (log scale) |
RV function and markers of RV-PA coupling · baseline
- No significant differences
RV function (RVFWS, tricuspid annular plane systolic excursion (TAPSE), fractional area change (FAC)) · early follow-up (3 months)
- RVFWS
- −20.9 ± 4.3 vs. −18.5 ± 5.1%
- TAPSE
- 19.7 ± 5.1 vs. 17.4 ± 4.9 mm
- FAC
- 39.7 ± 8.5 vs. 35.2 ± 9.4%
- Better RV function in patients with long-term LVEF improvement
- All P < 0.01
RV-PA coupling (RVFWS/PASP, TAPSE/PASP, FAC/PASP) · early follow-up
- RVFWS/PASP
- 0.82 ± 0.35 vs. 0.65 ± 0.35%/mmHg
- TAPSE/PASP
- 0.71 (0.55-1.00) vs. 0.54 (0.35-0.75) mm/mmHg
- FAC/PASP
- 1.54 ± 0.61 vs. 1.24 ± 0.75%/mmHg
- Worse RV-PA coupling in non-improvers
- All P < 0.01
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →